Alto Neuroscience (NYSE:ANRO) Coverage Initiated at Wedbush

Wedbush started coverage on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report released on Tuesday morning, MarketBeat reports. The brokerage issued an outperform rating and a $29.00 price objective on the stock. Wedbush also issued estimates for Alto Neuroscience’s Q3 2024 earnings at ($0.61) EPS, Q4 2024 earnings at ($0.65) EPS, FY2024 […]